1
|
Cunningham A, Benediktsson H, Muruve DA,
Hildebrand AM and Ravani P: Trends in biopsy-based diagnosis of
kidney disease: A population study. Can J Kidney Health Dis.
5:20543581187996902018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Huang YM, Xu D, Long J, Shi Y, Zhang L,
Wang H, Levin A and Zhao MH: The spectrum of chronic kidney disease
in China: A national study based on hospitalized patients from 2010
to 2015. Nephrology (Carlton). 24:725–736. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Pontrelli P, Oranger A, Barozzino M,
Divella C, Conserva F, Fiore MG, Rossi R, Papale M, Castellano G,
Simone S, et al: Deregulation of autophagy under hyperglycemic
conditions is dependent on increased lysine 63 ubiquitination: A
candidate mechanism in the progression of diabetic nephropathy. J
Mol Med (Berl). 96:645–659. 2018. View Article : Google Scholar : PubMed/NCBI
|
4
|
Dai H, Liu Q and Liu B: Research progress
on mechanism of podocyte depletion in diabetic nephropathy. J
Diabetes Res. 2017:26152862017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Yamaguchi Y, Iwano M, Suzuki D, Nakatani
K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, et al:
Epithelial-mesenchymal transition as a potential explanation for
podocyte depletion in diabetic nephropathy. Am J Kidney Dis.
54:653–664. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ghaleb AM and Yang VW: Krüppel-like factor
4 (KLF4): What we currently know. Gene. 611:27–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Yoshida T, Yamashita M, Iwai M and Hayashi
M: Endothelial krüppel-like factor 4 mediates the protective effect
of statins against ischemic AKI. J Am Soc Nephrol. 27:1379–1388.
2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Hayashi K, Sasamura H, Nakamura M, Azegami
T, Oguchi H, Sakamaki Y and Itoh H: KLF4-dependent epigenetic
remodeling modulates podocyte phenotypes and attenuates
proteinuria. J Clin Invest. 124:2523–2537. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gong J, Jin J, Zhao L, Li Y, Li Y and He
Q: Tripterygium glycoside protects against puromycin amino
nucleoside-induced podocyte injury by upregulating autophagy. Int J
Mol Med. 42:115–122. 2018.PubMed/NCBI
|
10
|
Tesch GH and Lim AK: Recent insights into
diabetic renal injury from the db/db mouse model of type 2 diabetic
nephropathy. Am J Physiol Renal Physiol. 300:F301–F3010. 2011.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Mallipattu SK, Guo Y, Revelo MP, Roa-Peña
L, Miller T, Ling J, Shankland SJ, Bialkowska AB, Ly V, Estrada C,
et al: Krüppel-Like factor 15 mediates glucocorticoid-induced
restoration of podocyte differentiation markers. J Am Soc Nephrol.
28:166–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Mallipattu SK, Estrada CC and He JC: The
critical role of Krüppel-like factors in kidney disease. Am J
Physiol Renal Physiol. 312:F259–F265. 2017. View Article : Google Scholar : PubMed/NCBI
|
13
|
Vogelmann SU, Nelson WJ, Myers BD and
Lemley KV: Urinary excretion of viable podocytes in health and
renal disease. Am J Physiol Renal Physiol. 285:F40–F48. 2003.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Loeffler I and Wolf G:
Epithelial-to-mesenchymal transition in diabetic nephropathy: Fact
or fiction. Cells. 4:631–652. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lin L, Han Q, Xiong Y, Li T, Liu Z, Xu H,
Wu Y, Wang N and Liu X: Krüpple-like-factor 4 attenuates lung
fibrosis via inhibiting epithelial-mesenchymal transition. Sci Rep.
7:158472017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen WC, Lin HH and Tang MJ:
Matrix-stiffness-regulated inverse expression of Krüppel-like
factor 5 and Krüppel-like factor 4 in the pathogenesis of renal
fibrosis. Am J Pathol. 185:2468–2481. 2015. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pinho AV, Rooman I and Real FX:
p53-dependent regulation of growth, epithelial-mesenchymal
transition and stemness in normal pancreatic epithelial cells. Cell
Cycle. 10:1312–1321. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wada J and Makino H: Inflammation and the
pathogenesis of diabetic nephropathy. Clin Sci (Lond). 124:139–152.
2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Li Z, Jia Y, Han S, Wang X, Han F, Zhang
J, Zhang W, Guan H and Hu D: Klf4 alleviates
lipopolysaccharide-induced inflammation by inducing expression of
MCP-1 induced protein 1 to deubiquitinate TRAF6. Cell Physiol
Biochem. 47:2278–2290. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Jin J, Wu D, Zhao L Zou W, Shen W, Tu Q
and He Q: Effect of autophagy and stromal interaction molecule 1 on
podocyte epithelial-mesenchymal transition in diabetic nephropathy.
Int J Clin Exp Pathol. 5:2450–2459. 2018.
|
22
|
Lenoir O, Jasiek M, Hénique C, Guyonnet L,
Hartleben B, Bork T, Chipont A, Flosseau K, Bensaada I, Schmitt A,
et al: Endothelial cell and podocyte autophagy synergistically
protect from diabetes-induced glomerulosclerosis. Autophagy.
11:1130–1145. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Tagawa A, Yasuda M, Kume S, Yamahara K,
Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K,
et al: Impaired podocyte autophagy exacerbates proteinuria in
diabetic nephropathy. Diabetes. 65:755–767. 2016. View Article : Google Scholar : PubMed/NCBI
|
24
|
Riz I, Hawley TS and Hawley RG:
KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to
carfilzomib resistance in multiple myeloma models. Oncotarget.
6:14814–14831. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Liu C, DeRoo EP, Stecyk C, Wolsey M,
Szuchnicki M and Hagos EG: Impaired autophagy in mouse embryonic
fibroblasts null for Krüppel-like Factor 4 promotes DNA damage and
increases apoptosis upon serum starvation. Mol Cancer. 14:1012015.
View Article : Google Scholar : PubMed/NCBI
|